![](/img/cover-not-exists.png)
[Topics in Medicinal Chemistry] Protein Therapeutics Volume 21 || Immunogenicity Lessons Learned from the Clinical Development of Vatreptacog Alfa, A Recombinant Activated Factor VII Analog, in Hemophilia with Inhibitors
Sauna, Zuben E., Kimchi-Sarfaty, ChavaVolume:
10.1007/97
Year:
2017
Language:
english
DOI:
10.1007/7355_2016_1
File:
PDF, 900 KB
english, 2017